缓解帕金森病患者症状的非侵入性设备:多中心II期双盲随机对照试验的研究方案
Viktoria Azoidou1, Essa Bhadra2, Kira Rowsell3
1Wolfson Institute of Population Health, Queen Mary University of London, London, UK v.azoidou@qmul.ac.uk.
BMJ open
|April 27, 2025
概括
本研究评估了用于帕金森病 (PD) 患者的CUE1+设备,评估其可用性和有效性,以改善步态和减少跌倒. 早期的结果表明,CUE1+可能为治疗PD症状提供了一个有前途的新干预措施.
科学领域:
- 神经学 神经学
- 生物医学工程 生物医学工程
- 临床试验 临床试验
背景情况:
- 帕金森病 (PD) 由于步态障碍和跌倒,显著影响生活质量.
- 目前的干预措施往往不足以解决这些特定的运动症状.
- 使用振动刺激的CUE1+装置显示出缓解症状的潜力.
研究的目的:
- 评估CUE1+装置在患有帕金森病 (PwP) 的患者中的可用性,安全性和有效性.
- 在12周的时间内,将CUE1+设备与假装设备进行比较.
- 评估CUE1+对PwP运动症状,步态和摔倒的影响.
主要方法:
- 一个多中心,二期双盲随机对照试验,涉及50名PwP.
- 随机分配到CUE1+设备或假装设备组.
- 主要结果:设备的可用性;次要结果:通过临床日记,运动测试,腕带监测和患者报告的结果来衡量安全性,耐受性和有效性.
主要成果:
- 将监控招聘,合规和学率.
- 通过参与者的临床日记评估安全性和耐受性.
- 使用标准化运动测试和患者报告的结果措施来评估有效性.
结论:
- 这项研究将提供关于CUE1+装置作为帕金森病干预措施的潜力的关键数据.
- 研究结果将为开发非侵入性治疗方法提供信息,用于PwP的步行障碍和跌倒.
- 成功的结果可能会改善帕金森病患者的生活质量.
相关概念视频
Parkinson's Disease: Treatment
148
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
148
Parkinson's Disease: Overview
308
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
308
Neural Regulation
39.0K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.0K


